033270 Stock Chart & Stats
₩17490.00
₩80.00(0.46%)
―
--
Day’s Range― - ―
52-Week Range₩16,460.00 - ₩21,900.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)27.80K
Market Cap
₩253.77B
Enterprise ValueN/A
Total Cash (Recent Filing)₩171.65B
Total Debt (Recent Filing)₩13.32B
Price to Earnings (P/E)6.6
Beta0.12
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2633.27
Shares Outstanding15,910,775
10 Day Avg. Volume28,720
30 Day Avg. Volume27,803
Financial Highlights & Ratios
PEG Ratio0.39
Price to Book (P/B)0.69
Price to Sales (P/S)1.08
P/FCF Ratio11.25
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)2,798.5
Revenue Forecast (FY)₩299.20B
033270 FAQ
What was KOREA UNITED PHARM, INC.’s price range in the past 12 months?
KOREA UNITED PHARM, INC. lowest stock price was ₩16460.00 and its highest was ₩21900.00 in the past 12 months.
What is KOREA UNITED PHARM, INC.’s market cap?
KOREA UNITED PHARM, INC.’s market cap is ₩253.77B.
When is KOREA UNITED PHARM, INC.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were KOREA UNITED PHARM, INC.’s earnings last quarter?
Currently, no data Available
Is KOREA UNITED PHARM, INC. overvalued?
According to Wall Street analysts KOREA UNITED PHARM, INC.’s price is currently Undervalued.
Does KOREA UNITED PHARM, INC. pay dividends?
KOREA UNITED PHARM, INC. does not currently pay dividends.
What is KOREA UNITED PHARM, INC.’s EPS estimate?
KOREA UNITED PHARM, INC.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does KOREA UNITED PHARM, INC. have?
KOREA UNITED PHARM, INC. has 15,910,775 shares outstanding.
What happened to KOREA UNITED PHARM, INC.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of KOREA UNITED PHARM, INC.?
Currently, no hedge funds are holding shares in KR:033270
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
KOREA UNITED PHARM, INC.
Korea United Pharm Inc. is a South Korean enterprise dedicated to the development, production, and distribution of a wide array of pharmaceutical products. The company's extensive portfolio encompasses therapeutic solutions for various medical fields, such as the respiratory, musculoskeletal, gastrointestinal, cardiovascular, and central nervous systems, in addition to treatments for cancer, infections, allergies, and immune disorders. It also supplies over-the-counter drugs. While deeply rooted in the South Korean market, the firm extends its reach internationally, exporting its medications to nearly 40 countries. Founded in 1987, Korea United Pharm Inc. is headquartered in Seoul, South Korea.
ILSUNG IS CO., LTD.
―
YUNGJIN PHARM. CO. LTD
―
Suheung Co. Ltd.
―
Kwang Dong Pharmaceutical Co., Ltd.
―
JW Holdings Corporation
―